Cancer

Article	Citations
Issue Information	404
Sharp rise in esophageal cancer and Barrett esophagus seen in middle‐aged people	263
Issue Information	206
Stopping immunotherapy after 2 years is practical in patients with advanced non–small cell lung cancer	202
MRI is more accurate than a PSMA PET/CT scan for prostate cancer diagnosis	160
Updated American Cancer Society lung cancer screening guidelines	160
Issue Information	113
	111
Cutaneous β‐HPV may predict cutaneous squamous cell carcinoma	88
Issue Information	82
New standard of care for multiple myeloma?	81
	77
Erratum to “Landscape of DNA damage response gene alterations in breast cancer: A comprehensive investigation”	73
New test for detecting cervical adenocarcinoma	65
Accelerated approval of multiple myeloma therapies	64
	63
Cancer‐related impairments and functional limitations among long‐term cancer survivors: Gaps and opportunities for clinical practice	58
	56
Let's ask the patient: Self‐reported quality‐of‐life measures help to predict kidney cancer mortality	56
Occurrence of breast‐cancer–related lymphedema after reverse lymphatic mapping and selective axillary dissection versus standard surgical treatment of axilla: A two‐arm randomized clinical trial	56
Active Living After Cancer: Adaptation and evaluation of a community‐based physical activity program for minority and medically underserved breast cancer survivors	55
Association of the social disorganization index with time to first septic shock event in children with acute myeloid leukemia	54
Evaluation of headache in patients with cancer	53
Impact of African ancestry on the relationship between body mass index and survival in an early‐stage breast cancer trial (ECOG‐ACRIN E5103)	51
Impact of TAILORx on chemotherapy prescribing and 21‐gene recurrence score–guided treatment costs in a population‐based cohort of patients with breast cancer	51

Reply to “Empathic communication: The premise of inclusive care for historically excluded populations”	51
Understanding risk factors for cancer: What's new and how can it help reduce the cancer burden?	50
The economics of advanced and unresectable hepatocellular carcinoma	50
Patterns of failure in pediatric medulloblastoma and implications for hippocampal sparing	50
Potential of circulating tumor DNA to refine immunotherapy	48
Epistemic equity in oncology: Opportunities to leverage patient‐centric implementation in clinical trial design	48
What enhanced recovery means for patients with cancer undergoing surgery	48
Top advances of the year: Cervical cancer	48
Aspirin but not statins is inversely related to gastric cancer with a duration–risk effect: Results from the Stomach Cancer Pooling Project Consortium	47
Dietary supplement use among adult survivors of childhood cancer: A report from the St. Jude Lifetime Cohort Study	47
Can we avoid thoracic radiotherapy in young females with Hodgkin lymphoma?	47
	45
Lung cancer screening use and implications of varying eligibility criteria by race and ethnicity: 2019 Behavioral Risk Factor Surveillance System data	44
Detection of recurrent colorectal cancer with high specificity using a reporting threshold for circulating tumor DNA methylated in BCAT1 and IKZF1	44
What’s the reality for CDK4/6 inhibitors: Clinical trials or real‐world evidence?	43
Multicenter study of pediatric Epstein‐Barr virus–negative monomorphic post solid organ transplant lymphoproliferative disorders	43
Association of high‐dose radiotherapy with improved survival in patients with newly diagnosed low‐grade gliomas	43
Redefining the “crown”: Approaching chemotherapy‐induced alopecia among Black patients with breast cancer	42
Effect of smoking reduction, cessation, and resumption on cancer risk: A nationwide cohort study	42
Long‐term follow‐up of a phase 2 study of all‐trans retinoic acid, arsenic trioxide, and gemtuzumab ozogamicin in acute promyelocytic leukemia	42
Risk scores predicting disease progression in early‐stage chronic lymphocytic leukemia: Comparative analysis and usefulness of IGHV subset #2 to improve their accuracy	41
Improved survival and decreased cancer deaths in young adults with cancer after passage of the Affordable Care Act Dependent Coverage Expansion	41
Midlife baseline prostate‐specific antigen, velocity, and doubling time association with lethal prostate cancer and mortality	41
Reply to “Enhancing the role of social work in managing cancer risks among LGBTQ+ populations” and “The urgency of systematically acquiring sexual orientation and gender identity data (SOGI) to ensure	41
A comparison of isolated limb infusion/perfusion, immune checkpoint inhibitors, and intralesional therapy as first‐line treatment for patients with melanoma in‐transit metastases	40
Erratum to “Unhealthy lifestyle behaviors, overweight, and obesity among childhood cancer survivors in the Netherlands: A DCCSS LATER study”	40
Implantable cardioverter defibrillators in people dying with cancer: A SEER‐Medicare analysis of ICD prevalence and association with aggressive end‐of‐life care	40
The Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer (CISTO) study: Lessons learned about management and patient enrollment in a large, pragmatic, patient‐centere	40
Targeting HER2 in lung cancers: Evolving treatment landscape and drug development strategies	39
Serum of interleukin‐6 and procalcitonin as early diagnostic markers for the identification of poor hematopoietic reconstitution following allogeneic hematopoietic stem cell transplantation	38
“Cancer Statistics, 2025” provides data on cancer occurrence and outcomes	38
Erratum to “Incorporation of alemtuzumab into frontline therapy of adult acute lymphoblastic leukemia: Results of Cancer and Leukemia Group B 10102 (Alliance), a phase 1/2 study”	38
Implications of omitting sentinel lymph node biopsy on adjuvant decision making for patients with small breast cancers	37
Top advances of the year: Neoadjuvant immunotherapy in melanoma	37
Ovarian juvenile granulosa cell tumor: A report from the International Ovarian and Testicular Stromal Tumor and International Pleuropulmonary Blastoma/DICER1 Registries	37
Disparities in prostate cancer screening, diagnoses, management, and outcomes between Indigenous and non‐Indigenous men in a universal health care system	36
Erratum to “Chimeric antigen receptor–based immunotherapy in breast cancer: Recent progress in China”	36
Best of both worlds? Linking comprehensive and noncomprehensive cancer centers	36
Symptomatic androgen deficiency and sexual dysfunctions in male patients receiving alectinib for ALK‐positive advanced non–small cell lung cancer	35
Smoking cessation services and shared decision‐making practices among lung cancer screening facilities: A cross‐sectional study	35
International perspectives on the development, application, and evaluation of a multicancer early detection strategy	35
Characteristics of clinical trials of new oncology drugs approved in China	35
Impact of pretransplant minimal residual disease in patients with multiple myeloma and a very good partial response or better receiving autologous hematopoietic stem cell transplantation	35
Association between visceral adiposity index and cancer risk in the UK Biobank cohort	35
The critical need to implement and utilize patient‐reported measures of function in cancer care delivery	35
Active surveillance after neoadjuvant chemoradiotherapy for esophageal cancer	35
Radiation necrosis in renal cell carcinoma brain metastases treated with checkpoint inhibitors and radiosurgery: An international multicenter study	35
Outcomes of patients with newly diagnosed acute myeloid leukemia with FLT3‐tyrosine kinase domain mutations: Prognostic implications of NPM1 co‐mutation	34
Significance of HIV status in cervical cancer patients receiving curative chemoradiation therapy, definitive radiation alone, or palliative radiation in Botswana	34
What are the most effective exercise, physical activity and dietary interventions to improve body composition in women diagnosed with or at high‐risk of breast cancer? A systematic review and network	34

Effect of an mHealth intervention on physical activity outcomes among young adult cancer survivors: The IMPACT randomized controlled trial	33
A guide to large data sets for population‐based cancer research: Strengths, limitations, and pitfalls	32
Disparities and trends in the participation of minorities, women, and the elderly in breast, colorectal, lung, and prostate cancer clinical trials	32
Recent histone deacetylase inhibitors in cancer therapy	32
The role of relative advantage for development of sequencing‐based diagnostics for pediatric cancer in low‐ and middle‐income countries	32
Breast cancer survival in India across 11 geographic areas under the National Cancer Registry Programme	31
Issue Information	31
Issue Information	31
Financial toxicity impact on younger versus older adults with cancer in the setting of care delivery	31
Keep moving to prevent cancer	31
Issue Information	31
Family characteristics and childcare patterns associated with early social functioning in cancer‐bereaved parents	31
	31
Issue Information	31
Comparison of long‐term outcomes between imatinib and dasatinib prophylaxis after allogeneic stem cell transplantation in patients with Philadelphia‐positive acute lymphoblastic leukemia: A multicente	30
Making a case for del(1p) as a high‐risk abnormality in multiple myeloma	30
Seroconversion and outcomes after initial and booster COVID‐19 vaccination in adults with hematologic malignancies	30
Safety, efficacy, and pharmacokinetics of SH‐1028 in EGFR T790M‐positive advanced non–small cell lung cancer patients: A dose‐escalation phase 1 study	30
Clinical implications of tumor‐based next‐generation sequencing in high‐grade epithelial ovarian cancer	29
Obesity in adult acute myeloid leukemia is not associated with inferior response or survival even when dose capping anthracyclines: An ECOG‐ACRIN analysis	29
Treatment of children with favorable histology Wilms tumor with extrapulmonary metastases: A report from the COG studies AREN0533 and AREN03B2 and NWTSG study NWTS‐5	29
A Coala‐T‐Cannabis Survey Study of breast cancer patients' use of cannabis before, during, and after treatment	28
Impact of the COVID‐19 pandemic on pediatric oncology providers globally: A mixed‐methods study	28
Real‐world treatment patterns and outcomes with oral azacitidine maintenance therapy in patients with acute myeloid leukemia	28
Triple‐negative breast cancer survival prediction using artificial intelligence through integrated analysis of tertiary lymphoid structures and tumor budding	28
Impact of baseline tumor burden on overall survival in patients with radioiodine‐refractory differentiated thyroid cancer treated with lenvatinib in the SELECT global phase 3 trial	28
Utilization and perceptions of chaplaincy among hospitalized adults of Dharmic religions with cancer	28
	27
Association between sustained virological response and clinical outcomes in patients with hepatitis C infection and hepatocellular carcinoma	27
Effect of preoperative programmed death‐1 or programmed death ligand‐1 immune check point inhibition on complications after surgery for primary head and neck cancer	27
Helping patients with cancer to understand secondary findings on genetic tests	27
	27
Physical fitness and clinically assessed disease burden in long‐term childhood cancer survivors—The SURfit study	27
Acute hospitalizations after proton therapy versus intensity‐modulated radiotherapy for locally advanced non–small cell lung cancer in the durvalumab era	26
Immune check point inhibitors in advanced cutaneous squamous cell carcinomas: “Repeat and replicate”	26
Peripheral blood parameter abnormalities precede therapy‐related myeloid neoplasms after autologous transplantation for lymphoma	26
Quality of life, psychological distress, and prognostic perceptions in patients with multiple myeloma	26
Increased health‐related quality of life impairments of male and female survivors of childhood cancer: DCCSS LATER 2 psycho‐oncology study	26
Lost in the shadow of giants: The neglected treatment modalities in oncologic trials	26
Cusatuzumab for treatment of CD70‐positive relapsed or refractory cutaneous T‐cell lymphoma	26
Avelumab treatment for patients with metastatic Merkel cell carcinoma can be safely stopped after 1 year and a PET/CT–confirmed complete response	26
Cervical cancer elimination in Indian context: Moving from barriers to facilitators	26
Beyond the PSA: The hidden costs of screening in prostate cancer	25
A randomized prospective trial of an ostomy telehealth intervention for cancer survivors	25
	25
Select cases might get a benefit from chemotherapy for Stage I pT1aN0M0 HER2+ breast cancer	25
The Prostate Cancer Active Lifestyle Study (PALS): A randomized controlled trial of diet and exercise in overweight and obese men on active surveillance	25
Continuity and coordination of care for childhood cancer survivors with multiple chronic conditions: Results from the Childhood Cancer Survivor Study	25
The use of national datasets to evaluate outcomes for invasive lobular carcinoma	25
Young adult males have worse survival than females that is largely independent of treatment received for many types of central nervous system tumors: A National Cancer Database analysis	25
Racial inequities in the quality of surgical care among Medicare beneficiaries with localized prostate cancer	24
Association between treatment‐emergent hypertension and survival with lenvatinib treatment for patients with hepatocellular carcinoma in the REFLECT study	24
Fecal microbiota transplantation for immunotherapy‐resistant urological tumors: Is it time? An update of the recent literature	24
Targeting ROS1 rearrangements in non–small cell lung cancer: Current insights and future directions	23
Correlation analysis of invasive disease‐free survival and overall survival in a real‐world population of patients with HR+/HER2– early breast cancer	23
Is it time for bone marrow sparing radiation therapy to be standard of care in cervical cancer?	23
Anti‐Müllerian hormone for assessing ovarian toxicity of cancer treatment in young women: It’s complicated	23
Standard of care for children with newly diagnosed B‐cell ALL	23
Olaparib in treatment‐refractory isocitrate dehydrogenase 1 (IDH1)– and IDH2‐mutant cholangiocarcinoma: Safety and antitumor activity from the phase 2 National Cancer Institute 10129 tri	23
From childhood cancer to metabolic syndrome	23
Estimating oncologist variability in prescribing systemic cancer therapies to patients in the last 30 days of life	23
Associations between experiences of discrimination and quality of life in Black breast cancer survivors	23
Anlotinib in combination with docetaxel for advanced nonsmall cell lung cancer after failure of platinum‐based treatment: A phase 1/2 trial	23
The protective role of postoperative radiation therapy in low and intermediate grade major salivary gland malignancies: A study of the Canadian Head and Neck Collaborative Research Initiative	23
Prevalence and determinants of metabolic syndrome in 2338 childhood cancer survivors: A Dutch Childhood Cancer Survivor LATER 2 study	23
Impact of acupuncture and integrative therapies on chemotherapy‐induced peripheral neuropathy: A multicentered, randomized controlled trial	22
Outcomes of radiofrequency ablation for hepatocellular carcinoma with concurrent steatotic liver disease	22
Associations between geography, decision‐making style, and interest in cancer clinical trial participation	22
Improving the quality of care for patients with advanced epithelial ovarian cancer: Program components, implementation barriers, and recommendations	22
Diabetes mellitus and neurocognition: A report from the Childhood Cancer Survivor Study	22
Association of mental health treatment receipt with cancer screening among US adults with a history of anxiety or depression	22
Single‐agent belantamab mafodotin in patients with relapsed/refractory multiple myeloma: Final analysis of the DREAMM‐2 trial	21
A phase 1 study of triple‐targeted therapy with BRAF, MEK, and AKT inhibitors for patients with BRAF‐mutated cancers	21
Palliative care training can help patients with advanced cancer at the end of life	21
First person profile: Robert C. Bast Jr MD	21
The American Cancer Society National Lung Cancer Roundtable strategic plan: Introduction	21
Landscape and clinical impact of NOTCH mutations in newly diagnosed acute myeloid leukemia	21
Lung cancer screening associated with earlier diagnosis and improved survival	21
Sex disparities in the incidence of 21 cancer types: Quantification of the contribution of risk factors	21
A call to action to advance patient‐focused and decentralized clinical trials	21

Is repeat breast conservation possible for small ipsilateral breast cancer recurrence?	21
Targeted genotyping for recurring variants in cancer susceptibility genes in non‐Ashkenazi Jewish patients with breast cancer diagnosed ≥50 years	20
The impact of the COVID‐19 pandemic on African American cancer survivors	20
	20
Endoscopic balloon cryoablation plus transurethral resection for bladder cancer: A phase 2, multicenter, randomized, controlled trial	20
Cumulative incidence and risk factors of brain metastases in metastatic non–small cell lung cancer without baseline brain metastasis: Pooled analysis of individualized patient data from IMpower130, IM	20
Cancer treatment in the time of COVID‐19 pandemics: A new concern	20
Association between the amount of artificial hydration and quality of dying among terminally ill patients with cancer: The East Asian Collaborative Cross‐Cultural Study to Elucidate the Dying Process	20
Defining disease modification in myelofibrosis in the era of targeted therapy	20
Stage I epithelial or stromal type Wilms tumors are low risk tumors: An analysis of patients treated on the SIOP‐WT‐2001 protocol in the UK‐CCLG and GPOH studies (2001–2020)	20
Hepatocellular carcinoma, vascular endothelial growth factor receptors‐targeting agents, and hypertension: A much more complicated relationship than expected	20
Breast health equity along the cancer care continuum: A collaborative grant initiative	20
Association between exposures to radon and γ‐ray radiation and histologic type of lung cancer in Eldorado uranium mining and milling workers from Canada	20
Reply to “Another look at floor and ceiling effects in the EORTC QLQ‐C30 Physical Functioning subscale and possible solutions”	20
An editorial on a comparison of care quality metrics between Black and White men with advanced prostate cancer in the IRONMAN registry	20
Multidimensional structural racism and estimated cancer risk from traffic‐related air pollution	19
Treatment patterns and outcomes in secondary acute myeloid leukemia arising after hypomethylating agents: PETHEMA registry study	19
AACR 2024 presents advancements in pancreatic and gastric cancers	19
Oncologists’ role in end‐of‐life chemotherapy and patient‐centered care	19
Evolving patterns and clinical outcome of genetic studies performed at diagnosis in acute myeloid leukemia patients: Real life data from the PETHEMA Registry	19
Health‐related quality of life outcomes after neoadjuvant chemoradiotherapy for rectal cancer in NRG Oncology/NSABP R‐04	19
The relationship of mental health symptoms to chemotherapy toxicity risk in older adults with cancer: Results from the geriatric assessment–driven intervention study	19
CCNE1 and survival of patients with tubo‐ovarian high‐grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study	19
Gaps in care highlight the need to expand access to clinical cancer trials	19
Issue Information	19
First person profile: Fadlo R. Khuri, MD	19
Staging lymph nodes and blood at diagnosis in mycosis fungoides identifies patients at increased risk of progression to advanced stage: A retrospective cohort study	19
Geographic diffusion of digital mammography in the United States	19
Issue Information	19
Pembrolizumab with chemoradiotherapy followed by pembrolizumab for stage III–IVa cervical cancer: is the ENGOT‐cx11/GOG‐3047/KEYNOTE‐A18 trial practice changing?	19
Erratum to “Benefit of delayed primary excision in rhabdomyosarcoma: A report from the Children’s Oncology Group”	19
Nomogram predicts survival and surgical benefits for patients with breast cancer with initial bone metastasis: A population‐based study	19
Assessment of the compliance, influencing factors, and yielding results of liver cancer screening in a high‐risk population: A cross‐sectional study	19
CD123 expression linked to high‐risk disease in children with acute myeloid leukemia	19
Cannabis use among adults undergoing cancer treatment	18
Burden of female‐specific cancers in China from 1990 to 2021: A systematic analysis for the Global Burden of Disease Study 2021	18
A phase 2 multicenter study of docetaxel‐PM and trastuzumab‐pkrb combination therapy in recurrent or metastatic salivary gland carcinomas	18
A prospective study on diagnostic accuracy of technology‐enabled early detection of oral cancer and epidemiology of tobacco and other substances use in rural India	18
Effects of exercise therapy on chemotherapy delivery and response in primary breast cancer: A secondary analysis of a randomized trial	18
Glioma mutational signatures associated with haloalkane exposure are enriched in firefighters	18
Association of mental health diagnosis with race and all‐cause mortality after a cancer diagnosis: Large‐scale analysis of electronic health record data	18
Alarming recent rises in early‐onset colorectal cancer	18
Top advances of the year: Targeted therapy for lung cancer	18
Cyclin‐dependent kinase inhibitors enhance programmed cell death protein 1 immune checkpoint blockade efficacy in triple‐negative breast cancer by affecting the immune microenvironment	18
Associations of serum trimethylamine N‐oxide and its precursors with colorectal cancer risk in the Prostate, Lung, Colorectal, Ovarian Cancer Screening Trial Cohort	18
Disease characteristics and mortality among Asian women with breast cancer	18
Reasons for refusal of the human papillomavirus vaccine among young cancer survivors	17
Cytokine release syndrome in solid tumors	17
	17
Factors associated with prostate cancer screening among Hispanic men: Results from the Hispanic Community Health Study/Study of Latinos	17
Issue Information	17
Issue Information	17
Issue Information	17
Top advances of the year in colorectal cancer	17
Social determinants of health and cancer mortality in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort study	17
Phase 1 trial of intraperitoneal paclitaxel in patients with gastric adenocarcinoma and carcinomatosis or positive cytology	17
Implementation and evaluation of a remote geriatric assessment and intervention program in Brazil	17
	17
	17
Issue Information	17
Disparities in pancreatic cancer care and research in Native Americans: Righting a history of wrongs	17
Primary osteosarcoma of the ribs: A report from the Cooperative Osteosarcoma Study Group	17
Circulating tumor DNA‐based molecular residual disease detection for treatment monitoring in advanced melanoma patients	17
Comparison of survival outcomes for patients with Stage III vs de novo Stage IV breast cancer	17
	17
Systemic therapies at the end of life vary by patient and practice	17
Genomics likely are not the main driver in advanced prostate cancer overall survival rate disparities	17
Issue Information	17
Caring for caregivers in early‐phase clinical oncology trials	16
The evolving therapeutic revolution in adult acute lymphoblastic leukemia	16
Characterization of HER2‐low breast cancer in young women with germline BRCA1/2 pathogenetic variants: Results of a large international retrospective cohort study	16
Chronic conditions, cancer disparities, and the unique needs of Black women with ovarian cancer	16
Disparities in cancer genetics care by race/ethnicity among pan‐cancer patients with pathogenic germline variants	16
Top advances of the year: Cervical cancer	16
Parents’ and adolescents’ perspectives and understanding of information about childhood cancer precision medicine	16
Incidence rates of soft tissue sarcoma among U.S. military servicemen: Comparison with the rates in the general U.S. population	16
Potential new standard of care for the first‐line treatment of metastatic colorectal cancer	16
Issue Information	16
American Radium Society Appropriate Use Criteria for the use of liver‐directed therapies for nonsurgical management of liver metastases: Systematic review and guidelines	16
First person profile: Julie Brahmer, MD	16
Associations between birth defects with neural crest cell origins and pediatric embryonal tumors	16
Insulin resistance during androgen deprivation therapy in men with prostate cancer	16
Historical redlining and survival among children, adolescents, and young adults with cancer diagnosed between 2000–2019 in Seattle and Tacoma, Washington	16
Impact of resistance training on inflammatory biomarkers and associations with treatment outcomes in colon cancer	16
Electronic health intervention to manage symptoms of immunotherapy in patients with cancer (SOFIA): Results from a randomized controlled pilot trial	16
	16
The cost burden of metastatic prostate cancer in the US populations covered by employer‐sponsored health insurance	16
Safety and effectiveness of the radium‐223–taxane treatment sequence in patients with metastatic castration‐resistant prostate cancer in a global observational study (REASSURE)	16
Cancer registries: A look back and forward	16
Racial disparities in the screening mammography continuum within a heterogeneous health care system	15
Delineation of features, responses, outcomes, and prognostic factors in pediatric PDGFRB‐positive acute lymphoblastic leukemia patients: A retrospective multicenter study	15
Cancer incidence in the US military: An updated analysis	15
New persistent opioid use among adolescents and young adults with sarcoma	15
	15
Generalizing approaches to surveillance for complex social outcomes in broad‐range patient populations—The cost in terms of lost information and subgroup utility	15